Pharmacyclics Stock Filter Stocks by Fundamentals
Pharmacyclics fundamentals help investors to digest information that contributes to Pharmacyclics' financial success or failures. It also enables traders to predict the movement of Pharmacyclics Stock. The fundamental analysis module provides a way to measure Pharmacyclics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmacyclics stock.
Pharmacyclics |
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
Pharmacyclics Fundamentals
Return On Asset | 0.1 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 8.51 B | |||
Shares Outstanding | 75.25 M | |||
Shares Owned By Insiders | 18.97 % | |||
Shares Owned By Institutions | 69.20 % | |||
Number Of Shares Shorted | 2.37 M | |||
Price To Earning | 284.59 X | |||
Price To Book | 22.47 X | |||
Price To Sales | 24.67 X | |||
Revenue | 729.73 M | |||
Gross Profit | 463.31 M | |||
Net Income | 86.12 M | |||
Cash And Equivalents | 845.03 M | |||
Cash Per Share | 11.50 X | |||
Total Debt | 6.38 M | |||
Debt To Equity | 0.28 % | |||
Current Ratio | 5.54 X | |||
Cash Flow From Operations | 183.77 M | |||
Earnings Per Share | 0.92 X | |||
Number Of Employees | 634 | |||
Beta | 0.55 | |||
Market Capitalization | 9.24 B | |||
Total Asset | 1.06 B | |||
Retained Earnings | (130.47 M) | |||
Working Capital | 821.32 M | |||
Current Asset | 1.02 B | |||
Current Liabilities | 194.24 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pharmacyclics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Pharmacyclics Stock
If you are still planning to invest in Pharmacyclics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmacyclics' history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |